TP53 Mutations and Lung Cancer: Not All Mutations Are Created Equal

被引：26

作者：

Govindan, Ramaswamy ^{[1
,2
]}

Weber, Jason ^{[1
,2
]}

机构：

[1] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA

[2] Washington Univ, Alvin J Siteman Canc Ctr, St Louis, MO 63110 USA

来源：

CLINICAL CANCER RESEARCH | 2014年 / 20卷 / 17期

关键词：

P53; MUTATIONS; MUTANT P53; SURVIVAL; CARCINOMA; RAS;

D O I：

10.1158/1078-0432.CCR-14-0899

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Mutations in TP53 are common in non-small cell lung cancer. Apart from the loss of tumor-suppressor functions, TP53 mutations may result in gain of function favoring cellular proliferation, inhibition of apoptosis, and genomic instability. Some TP53 mutations are more likely to affect the course of the disease than others. (C) 2014 AACR.

引用

页码：4419 / 4421

页数：3

共 50 条

[41] TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type
Rechsteiner, Markus
Zimmermann, Anne-Katrin
Wild, Peter J.
Caduff, Rosmarie
von Teichman, Adriana
Fink, Daniel
Moch, Holger
Noske, Aurelia
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2013, 95 (02) : 235 - 241
[42] Significance of TP53 mutations in human cancer:: a critical analysis of mutations at CpG dinucleotides
Soussi, T
Béroud, C
HUMAN MUTATION, 2003, 21 (03) : 192 - 200
[43] Air pollution and Tp53 mutations in bladder cancer in Spain
Castano-Vinyals, G.
Kogevinas, M.
Cantor, K. P.
Hernandez, S.
Lopez-Knowles, E.
Lloreta, J.
Tardon, A.
Garcia-Closas, R.
Serra, C.
Carrato, A.
Rothman, N.
Silverman, D. T.
Dosemeci, M.
Real, F. X.
Malats, N.
EPIDEMIOLOGY, 2006, 17 (06) : S366 - S366
[44] Breast-cancer stromal cells with TP53 mutations
Campbell, Ian G.
Qiu, Wen
Polyak, Kornelia
Haviv, Izhak
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (15): : 1634 - 1635
[45] Analysis of TP53 Mutations and HPV Infection in Esophageal Cancer
Khodahemmati, Sara
Ghaffar, Maliha
Li, Jin-Tao
Zhou, Zhi-Xiang
Zeng, Yi
2018 2ND INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING AND BIOINFORMATICS (ICBEB 2018), 2018, : 128 - 133
[46] TP53 gene mutations in plasma DNA of cancer patients
Silva, JM
Gonzalez, R
Dominguez, G
Garcia, JM
España, P
Bonilla, F
GENES CHROMOSOMES & CANCER, 1999, 24 (02): : 160 - 161
[47] TP53 mutations in familial breast cancer: Functional aspects
Gasco, M
Yulug, IG
Crook, T
HUMAN MUTATION, 2003, 21 (03) : 301 - 306
[48] TP53 Mutations Promote Immunogenic Activity in Breast Cancer
Liu, Zhixian
Jiang, Zehang
Gao, Yingsheng
Wang, Lirui
Chen, Cai
Wang, Xiaosheng
JOURNAL OF ONCOLOGY, 2019, 2019
[49] Clinical implications of germline mutations in breast cancer: TP53
Katherine Schon
Marc Tischkowitz
Breast Cancer Research and Treatment, 2018, 167 : 417 - 423
[50] TP53 mutations are not prognostic independent indicators in bladder cancer
Agnese, V.
Corsale, S.
Augello, C.
Bruno, L.
Calo, V.
Cammareri, P.
Cascio, S.
Gargano, G.
Gregorio, V.
Gullo, A.
La Rocca, G.
Sisto, P. S.
Valerio, M. R.
Di Fede, G.
Martorana, A.
Bazan, V.
Russo, A.
ANNALS OF ONCOLOGY, 2005, 16 : 152 - 152

← 1 2 3 4 5 →